• 
  Valentin Partula, Mélanie Deschasaux-Tanguy, Stanislas Mondot, Agnès Victor-Bala, Nadia Bouchemal, et al.. Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults. British Journal of Nutrition, Cambridge University Press (CUP), 2020, pp.1-29. ⟨10.1017/S0007114520004870⟩. ⟨hal-03073792⟩
• 
  Cindy Neuzillet, Amélie Anota, A.-M. Foucaut, Anne-Laure Védie, Sami Antoun, et al.. Nutrition and physical activity: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC, SFP-APA, SFNCM, AFSOS). BMJ Palliative and supportive care, BMJ Publishing Group 2020, bmjspcare-2020-002751. ⟨10.1136/bmjspcare-2020-002751⟩. ⟨hal-03038521⟩
• 
  Marion Berdal, Sébastien Gouard, Romain Eychenne, Séverine Marionneau-Lambot, Mikaël Croyal, et al.. Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chemical Science , The Royal Society of Chemistry, 2020, Online ahead of print. ⟨10.1039/D0SC05191H.⟩. ⟨inserm-03024891⟩
• 
  Catherine Uzan, Chafika Mazouni, Caroline Rossoni, Brigitte de Korvin, Christine Tunon de Lara, et al.. Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions. Annals of Surgical Oncology, Springer Verlag, 2020, ⟨10.1245/s10434-020-09107-z⟩. ⟨hal-03013819⟩
• 
  C. Chargari, S. Supiot, C. Hennequin, A. Chapel, J.-M. Simon. Traitement des effets tardifs après la radiothérapie : quoi de neuf ?. Cancer Radiothérapie, Elsevier Masson, 2020, 24 (6-7), pp.602-611. ⟨10.1016/j.canrad.2020.06.007⟩. ⟨hal-02969642⟩
• 
  Wolfgang Wick, Thierry Gorlia, Martin Bendszus, Martin Taphoorn, Felix Sahm, et al.. Lomustine and Bevacizumab in Progressive Glioblastoma. New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (20), pp.1954-1963. ⟨10.1056/NEJMoa1707358⟩. ⟨inserm-02940442⟩
• 
  Fabien Vidal, Paul Guerby, Mathieu Luyckx, Pascale Haddad, Eberhard Stoeckle, et al.. Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?. PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147787. ⟨10.1371/journal.pone.0147787⟩. ⟨inserm-02940269⟩
• 
  Florence Boissier, Valérie Seegers, Amélie Seguin, Stephane Legriel, Alain Cariou, et al.. Assessing physicians’ and nurses’ experience of dying and death in the ICU: development of the CAESAR-P and the CAESAR-N instruments. Critical Care, BioMed Central, 2020, 24 (1), ⟨10.1186/s13054-020-03191-z⟩. ⟨hal-02922649⟩
• 
  M. Caillot, J. Bourgeais, H. Dakik, É. Costé, N. Mazure, et al.. Oncogenesis Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis, Nature Publishing Group: Open Access Journals - Option C, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩. ⟨hal-02908131⟩
• 
  Sylvie Négrier, Nathalie Rioux-Leclercq, Céline Ferlay, Marine Gross-Goupil, Gwénaelle Gravis, et al.. Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial. European Journal of Cancer, Elsevier, 2020, 129, pp.107 - 116. ⟨10.1016/j.ejca.2020.02.001⟩. ⟨hal-02552562⟩
• 
  Clément Palpacuer, Karima Hammas, Renan Duprez, Bruno Laviolle, John P A Ioannidis, et al.. Vibration of effects from diverse inclusion/exclusion criteria and analytical choices 9216 different ways to perform an indirect comparison meta-analysis. BMC Medicine, BioMed Central, 2019, 17 (1), pp.174. ⟨10.1186/s12916-019-1409-3⟩. ⟨hal-02304653⟩
• 
  E. Mylona, A. Cicchetti, T. Rancati, F. Palorini, S. Supiot, et al.. Predicting urinary toxicity via 2D and 3D dose map analyses in prostate cancer radiotherapy. Radiotherapy and Oncology, Elsevier, 2019, 133, pp.S326-S326. ⟨10.1016/S0167-8140(19)31035-7⟩. ⟨hal-02177166⟩
• 
  E. Mylona, Oscar Acosta, T. Lizee, J. Castelli, C. Lafond, et al.. Bladder and urethra subregions predicting urinary toxicity after prostate cancer radiotherapy. Radiotherapy and Oncology, Elsevier, 2019, 133, pp.S449-S449. ⟨10.1016/S0167-8140(19)31273-3⟩. ⟨hal-02177163⟩
• 
  R Da-Ano, Ingrid Masson, Felix Lucia, M. Dore, Patrice Robin, et al.. Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.10248. ⟨10.1038/s41598-020-66110-w⟩. ⟨hal-02887419⟩
• 
  Fatima Tensaouti, Anne Ducassou, Leonor Chaltiel, Stéphanie Bolle, Jean Louis Habrand, et al.. Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Frontiers in Oncology, Frontiers, 2019, 9, pp.531. ⟨10.3389/fonc.2019.00531⟩. ⟨hal-02478956⟩
• 
  Cindy Pensec, Florence Gillaizeau, Dominique Guenot, Anne Bessard, Thomas Carton, et al.. Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.9094. ⟨10.1038/s41598-020-65792-6⟩. ⟨inserm-02884679⟩
• 
  J.-Y. Blay, C. Honore, E. Stoeckle, P. Méeus, M. Jafari, et al.. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Annals of Oncology, Elsevier, 2019, Annals of oncology official journal of the European Society for Medical Oncology, 30 (7), pp.1143-1153. ⟨10.1093/annonc/mdz124⟩. ⟨hal-02509515⟩
• 
  Emmanuelle Bompas, Loïc Campion, Antoine Italiano, Axel Le Cesne, Christine Chevreau, et al.. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, Wiley, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩. ⟨hal-01978221⟩
• 
  Loic Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Emmanuelle Bompas, Yves Toiron, et al.. Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO). Oncotarget, Impact journals, 2016, Oncotarget, 7 (45), pp.73984-73994. ⟨10.18632/oncotarget.12172⟩. ⟨hal-01453300⟩
• 
  Pauline Rochefort, Antoine Italiano, Valérie Laurence, Nicolas Penel, Audrey Lardy-Cleaud, et al.. A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome. Scientific Reports, Nature Publishing Group, 2017, Scientific reports, 7, ⟨10.1038/s41598-017-17733-z⟩. ⟨hal-02613645⟩

93

194